LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Repligen (NASDAQ: RGEN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ RGEN Repligen
Bylund James / officer: Chief Operating Officer
11/18/2025
Sell
$151.21
2,191
$331K
21,520
NASDAQ RGEN Repligen
Hunt Anthony / director
11/13/2025
Sell
$151.01
1,784
$269K
98,959
NASDAQ RGEN Repligen
Hunt Anthony / director
11/13/2025
Sell
$152.17
2,100
$320K
96,859
NASDAQ RGEN Repligen
Hunt Anthony / director
11/13/2025
Sell
$153.14
2,923
$448K
93,936
NASDAQ RGEN Repligen
Hunt Anthony / director
11/13/2025
Sell
$154.32
2,500
$386K
91,436
NASDAQ RGEN Repligen
Hunt Anthony / director
11/13/2025
Sell
$155.45
3,000
$466K
88,436
NASDAQ RGEN Repligen
Hunt Anthony / director
11/13/2025
Buy
$33.87
2,952
$100K
83,695
NASDAQ RGEN Repligen
Hunt Anthony / director
11/13/2025
Sell
$156.22
5,737
$896K
82,699
NASDAQ RGEN Repligen
Hunt Anthony / director
11/13/2025
Sell
$157.11
1,956
$307K
80,743
NASDAQ RGEN Repligen
Hunt Anthony / director
11/13/2025
Buy
$33.87
2,952
$100K
14,760
NASDAQ RGEN Repligen
Hunt Anthony / director
11/12/2025
Sell
$33.87
25,000
$847K
157,344
NASDAQ RGEN Repligen
Hunt Anthony / director
11/12/2025
Buy
$33.87
25,000
$847K
125,743
NASDAQ RGEN Repligen
Hunt Anthony / director
11/12/2025
Sell
$154.92
3,741
$580K
122,002
NASDAQ RGEN Repligen
Hunt Anthony / director
11/12/2025
Sell
$155.85
4,740
$739K
117,262
NASDAQ RGEN Repligen
Hunt Anthony / director
11/12/2025
Sell
$156.65
4,959
$777K
112,303
NASDAQ RGEN Repligen
Hunt Anthony / director
11/12/2025
Sell
$158.01
11,096
$1.753M
101,207
NASDAQ RGEN Repligen
Hunt Anthony / director
11/12/2025
Sell
$158.51
464
$74K
100,743
NASDAQ RGEN Repligen
Loeillot Olivier / director, officer: Chief Executive Officer
10/02/2025
Sell
$145.23
1,248
$181K
42,939
NASDAQ RGEN Repligen
Garland Jason K / officer: CFO
09/25/2025
Sell
$121.68
412
$50K
13,383